2022 American Transplant Congress

TOPIC: Clinical Science » Infection Disease

Heterologous Vaccine Schedule Against Sars-CoV-2 with 2 Doses of Inactivated Virus and a Booster of mRNA BNT162b2 in Kidney Transplant Recipients
M. Seija¹, F. Rammauro², J. Santiago¹, N. Orihuela³, C. Zulberti³, D. Machado⁴, C. Recalde⁴, J. Noboa¹, R. Astesiano¹, F. Yandian¹, A. Guerisoli¹, A. Morra³, D. Cassinelli¹, A. Pippolo¹, B. De Aramburu¹, C. Coelho¹, P. González¹, R. Romero¹, R. Rodriguez-Teja⁴, G. Acuña⁴, V. Rabaza⁴, N. Perg⁴, R. Cordero⁴, S. Orihuela³, L. Curi³, E. Burgstaller⁴, O. Noboa¹, O. Pritsch², M. Nin¹, S. Bianchi⁵
High Case Fatality Rate Among Fully Vaccinated Kidney Transplant Recipients with Breakthrough Covid-19 During the Delta Surge
K. Vieira, E. Klein, A. Lerner, D. Farmakioits
High Incidence of BKPyV DNAemia After Simultaneous Pancreas-Kidney Transplantation
I. Helanterä¹, J. Räihä¹, S. von Moos², I. Lautenschlager³, V. Sallinen¹, M. Lempinen¹, T. Schachtner²
High Level Cytomegalovirus Viremia in Liver Transplant Recipients: Risk Factors and Associated Outcomes
H. L. Kleiboeker¹, M. R. Jorgenson¹, G. E. Leverson², J. P. Rice³, C. M. Saddler⁴, J. A. Smith⁴, D. Al-Adra³
Higher Immunogenicity of a Third Heterologous Dose with BNT262b2 Mensanger RNA Vaccine Compared to a Homologous Dose in Kidney Transplant Recipients Fully Vaccinated with Inactivated Whole-Virion CoronaVac Vaccine
L. V. Pouzo¹, M. Nakamura¹, L. A. Viana², E. Lucena¹, M. Jesus¹, G. Bittencourt Pereira Lima¹, J. Medina¹, H. Tedesco¹, M. Cristelli¹
Higher Proinflammatory Cytokines Are Associated with Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients
A. H. Karaba¹, X. Zhu¹, S. E. Benner¹, O. Akinde¹, Y. Eby¹, K. H. Wang¹, S. Saraf², J. M. Garonzik-Wang³, S. L. Klein¹, J. R. Bailey¹, A. L. Cox¹, J. N. Blankson¹, C. M. Durand¹, D. L. Segev¹, W. A. Werbel¹, A. A. Tobian¹
HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients
R. Patil¹, R. Prashar², M. Ramesh², A. Patel²
Humoral and Cellular Immune Response to a Third Dose Of SARS-CoV-2 Vaccine in Kidney Transplant Recipients on Belatacept
J. Mitchell¹, J. Alejo¹, T. P. Chiang¹, J. N. Blankson¹, A. H. Karaba¹, B. Woldemeskel¹, C. Garliss¹, A. Chang¹, A. Abedon¹, R. K. Avery¹, A. Tobian¹, A. B. Massie¹, J. Garonzik-Wang², D. L. Segev¹, W. Werbel¹
Humoral and Cellular Immunity 6 Months After SARS-CoV-2 Infection in Solid-Organ Transplant Recipients
S. Morris¹, S. Courel², S. Pallikkuth³, S. Pahwa³, A. Fernandez⁴, S. Anjan¹, G. Guerra⁵, M. Alcaide¹, Y. Natori¹
Hypothermic Pulsatile Flush of Hepatitis C Virus (HCV) RNA Positive Kidney Reduces Viral Load
A. Jain¹, W. Greene²

« Previous Page
1
…
6
7
8
9
10
…
21
Next Page »